UC DAVIS (US)—Doctors may soon be able to diagnose the cause of pneumonia-like symptoms by examining the chemicals found in a patient’s urine.

Researchers at the University of California, Davis, used technology known as nuclear magnetic resonance spectroscopy, to identify a chemical “fingerprint” for the type of pneumonia caused by the bacterium Streptococcus pneumoniae, and compared it to the chemical fingerprints for other types of pneumonia and noninfectious lung diseases.

“This is the first study to demonstrate that NMR-based analysis of metabolites in urine has the potential to provide rapid diagnosis of the cause of pneumonia,” says Carolyn Slupsky assistant professor of nutrition, and food science and technology.

Findings from the study appear in the December issue of the Journal of Proteome Research. A patent is pending on the diagnostic procedure.

“It also shows that we can use this technology to quickly and easily monitor patient recovery,” Slupsky says. “The goal is a tool for rapid, accurate diagnosis so that patients can quickly begin treatment with the appropriate medication.”

Pneumonia is a lung infection that annually sickens millions of people in the United States, resulting in approximately 500,000 hospitalizations and thousands of deaths. A rapid, accurate diagnostic test for pneumonia could save lives by enabling doctors to begin appropriate treatment earlier.

Currently, pneumonia is diagnosed by a combination of clinical symptoms, X-rays, and analysis of a patient’s blood or sputum by bacterial culture. Such tests usually take more than 36 hours to complete and tend to yield a high rate of false-positive results.

Previous studies have shown that more than 80 percent of patients admitted to the hospital with pneumonia are misdiagnosed, leading to delays in treatment with the appropriate antibiotic.

In the new study, Slupsky and colleagues applied “metabolomics”—the study of the chemicals produced by the body’s metabolic processes—to develop a profile for pneumonia as it appears in a patient’s urine.

To do this, they analyzed hundreds of urine samples collected from both healthy individuals and patients with a variety of pulmonary diseases or infections. In the process, they measured 61 metabolites in urine samples using NMR spectroscopy.

They found that urine from patients infected with pneumonia caused by Streptococcus pneumoniae had a telltale chemical profile that clearly distinguished those people from healthy individuals or patients with other ailments.

“By analyzing urine samples collected at various intervals during the patient’s hospitalization, we could actually observe sick patients recover because their recovery was reflected in the chemical composition of their urine,” Slupsky explains.

She notes that the research team was surprised to find that most of the changes in metabolites related to infection by Streptococcus pneumoniae were caused by the body’s response to the infection rather than by the invading bacteria.

“In future studies, we hope to explore how bacteria and other microbes interact with the body of the individual they infect, and how these interactions alter metabolism in the body, resulting in unique metabolite profiles in the urine,” she says.

Slupsky collaborated on the study with researchers at the University of Alberta, University of Toronto, and Austin Health in Australia.

Funding was provided by the Alberta Heritage Foundation for Medical Research, the Lung Association of Alberta and the Northwest Territories, Western Economic Development, and Alberta Advanced Education and Technology.

University of California at Davis news: www.news.ucdavis.edu/